KALV logo

KalVista Pharmaceuticals (KALV) CAPEX

annual CAPEX:

N/A
April 30, 2024

Summary

  • KALV annual capital expenditures is not available.

Performance

KALV CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherKALVcash flow metrics

quarterly CAPEX:

N/A
January 31, 2025

Summary

  • KALV quarterly capital expenditures is not available.

Performance

KALV quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherKALVcash flow metrics

TTM CAPEX:

N/A
January 31, 2025

Summary

  • KALV TTM capital expenditures is not available.

Performance

KALV TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherKALVcash flow metrics

KALV CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

KALV CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

KALV CAPEX History

DateAnnualQuarterlyTTM
Apr 2020
$220.00K(-79.6%)
$8000.00(>+9900.0%)
$220.00K(-54.8%)
Jan 2020
-
$0.00(-100.0%)
$487.00K(-3.9%)
Oct 2019
-
$114.00K(+16.3%)
$507.00K(-17.4%)
Jul 2019
-
$98.00K(-64.4%)
$614.00K(-43.2%)
Apr 2019
$1.08M(-24.2%)
$275.00K(+1275.0%)
$1.08M(-42.8%)
Jan 2019
-
$20.00K(-91.0%)
$1.89M(-7.9%)
Oct 2018
-
$221.00K(-60.9%)
$2.05M(+9.0%)
Jul 2018
-
$565.00K(-47.9%)
$1.88M(+31.9%)
Apr 2018
$1.43M(+1828.4%)
$1.08M(+495.6%)
$1.43M(+316.0%)
Jan 2018
-
$182.00K(+256.9%)
$343.00K(+113.0%)
Oct 2017
-
$51.00K(-53.6%)
$161.00K(+46.4%)
Jul 2017
-
$110.00K(>+9900.0%)
$110.00K(-91.8%)
Apr 2017
$74.00K
-
-
Sep 2016
-
$0.00(-100.0%)
$1.34M(-1.5%)
DateAnnualQuarterlyTTM
Jun 2016
-
$61.00K(-66.8%)
$1.36M(-1.3%)
Apr 2016
$11.00K(-99.2%)
-
-
Mar 2016
-
$184.00K(-83.2%)
$1.38M(+0.3%)
Dec 2015
$1.37M(+999.2%)
$1.09M(+5109.5%)
$1.37M(+286.0%)
Sep 2015
-
$21.00K(-73.4%)
$356.00K(+4.1%)
Jun 2015
-
$79.00K(-56.1%)
$342.00K(+1.2%)
Apr 2015
$125.00K(-21.4%)
-
-
Mar 2015
-
$180.00K(+136.8%)
$338.00K(+112.6%)
Dec 2014
$159.00K(+783.3%)
$76.00K(+985.7%)
$159.00K(+91.6%)
Sep 2014
-
$7000.00(-90.7%)
$83.00K(+9.2%)
Jun 2014
-
$75.00K(+7400.0%)
$76.00K(+7500.0%)
Mar 2014
-
$1000.00
$1000.00
Dec 2013
$18.00K(-80.2%)
-
-
Dec 2012
$91.00K
-
-

FAQ

  • What is the all time high annual CAPEX for KalVista Pharmaceuticals?
  • What is the all time high quarterly CAPEX for KalVista Pharmaceuticals?
  • What is the all time high TTM CAPEX for KalVista Pharmaceuticals?

What is the all time high annual CAPEX for KalVista Pharmaceuticals?

KalVista Pharmaceuticals all-time high annual capital expenditures is $1.43M

What is the all time high quarterly CAPEX for KalVista Pharmaceuticals?

KalVista Pharmaceuticals all-time high quarterly capital expenditures is $1.09M

What is the all time high TTM CAPEX for KalVista Pharmaceuticals?

KalVista Pharmaceuticals all-time high TTM capital expenditures is $2.05M
On this page